Physician
Pediatric Hematology & Oncology
Dr. Jeffrey E. Rubnitz, MD
|
|
Give Review
Jeffrey Rubnitz works in the field of Pediatric Hematology & Oncology. He attended University of California San Diego School of Medicine. University of California San Diego School of Medicine is ranked 17 in research and 19 in primary care medicine Jeffrey E. Rubnitz is also a published MD. He has 81 publication published. The most recent publication is: Clinical significance of in vivo cytarabine-induced gene expression signature in AML.
Publications
- Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood Acute lymphoblastic leukaemia: a prospective study.
- Prognostic factors in children with Acute myeloid leukaemia and excellent response to remission induction therapy.
- Recent research and future prospects for gemtuzumab ozogamicin: could it make a comeback?
- Definition of cure in childhood Acute myeloid leukemia.
- A revised definition for cure of childhood Acute lymphoblastic leukemia.
- Feasibility, efficacy, and adverse effects of outpatient antibacterial prophylaxis in children with Acute myeloid leukemia.
- Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive Acute lymphoblastic leukemia.
- Methotrexate-Induced Neurotoxicity and Leukoencephalopathy in Childhood Acute Lymphoblastic Leukemia.
- Erratum to: Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
- Emergence of polyclonal FLT3 tyrosine kinase domain mutations during sequential therapy with sorafenib and sunitinib in FLT3-ITD-positive Acute myeloid leukemia.
- RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and Acute myeloid leukemia patients.
- Gemtuzumab ozogamicin can reduce minimal residual disease in patients with childhood Acute myeloid leukemia.
- Between-course targeting of methotrexate exposure using pharmacokinetically guided dosage adjustments.
- Voriconazole Prophylaxis in Children with Cancer: Changing Outcomes and Epidemiology of Fungal Infections.
- Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patients.
- Prognostic impact of absolute lymphocyte counts at the end of remission induction in childhood Acute lymphoblastic leukemia.
- Clinical Significance of CD33 Nonsynonymous Single-Nucleotide Polymorphisms in Pediatric Patients with Acute Myeloid Leukemia Treated with Gemtuzumab-Ozogamicin-Contai...
- Prognostic features in Acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group S...
- Sequential administration of methotrexate and asparaginase in relapsed or refractory pediatric Acute myeloid leukemia.
- Ontogeny and Sorafenib Metabolism.
- Childhood Acute myeloid leukaemia.
- Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia.
- Treatment outcome in older patients with childhood Acute myeloid leukemia.
- Effect of body mass index on the outcome of children with Acute myeloid leukemia.
- Treatment Outcomes in Black and White Children With Cancer: Results From the SEER Database and St Jude Children's Research Hospital, 1992 Through 2007.
- High-resolution genomic profiling of adult and pediatric core-binding-factor Acute myeloid leukemia reveals new recurrent genomic alterations.
- Genetic variants in cytosolic 5'-nucleotidase II are associated with its expression and cytarabine sensitivity in HapMap cell lines and in patients with Acute myeloid ...
- Combination chemotherapy with clofarabine, cyclophosphamide, and etoposide in children with refractory or relapsed haematological Malignancies.
- Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractor...
- Identification of a novel, tissue-specific ABCG2 promoter expressed in pediatric Acute megakaryoblastic leukemia.
- High success of hematopoietic cell transplantation regardless of donor source in children with very high-risk Leukemia.
- Prognostic significance of additional cytogenetic aberrations in 733 de novo pediatric 11q23/MLL-rearranged AML patients: results of an international study.
- Activity of the Multikinase Inhibitor Sorafenib in Combination With Cytarabine in Acute Myeloid Leukemia.
- Acute megakaryoblastic leukemia without GATA1 mutation after transient myeloproliferative disorder in an infant without Down syndrome.
- Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric Acute myeloid leukemia.
- Spinal epidural lipomatosis in children with hematologic Malignancies.
- Improved prognosis for older adolescents with Acute lymphoblastic leukemia.
- Isolated nasal septum necrosis caused by Aspergillus flavus in an immunocompromised child.
- Mechanisms of synergistic antileukemic interactions between valproic acid and cytarabine in pediatric Acute myeloid leukemia.
- NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood Acute myeloid leukemia.
- Combination of cladribine plus topotecan for recurrent or refractory pediatric Acute myeloid leukemia.
- Outcome of congenital Acute lymphoblastic leukemia treated on the Interfant-99 protocol.
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged Acute myeloid leukemia: results of an international retrospective study.
- Genomic analysis reveals few genetic alterations in pediatric Acute myeloid leukemia.
- Increased risk for CNS relapse in pre-B cell Leukemia with the t(1;19)/TCF3-PBX1.
- Combination of cladribine and cytarabine is effective for childhood Acute myeloid leukemia: results of the St Jude AML97 trial.
- Treating childhood Acute lymphoblastic leukemia without cranial irradiation.
- Cutaneous infection caused by Macrophomina phaseolina in a child with Acute myeloid leukemia.
- Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.
- Early T-cell precursor leukaemia: a subtype of very high-risk Acute lymphoblastic leukaemia.
- Clinical consequences of hyperglycemia during remission induction therapy for pediatric Acute lymphoblastic leukemia.
- Minimal residual disease quantitation in Acute myeloid leukemia.
- Clinical and biologic features and treatment outcome of children with newly diagnosed Acute myeloid leukemia and hyperleukocytosis.
- Prophylactic antibiotics reduce morbidity due to septicemia during intensive treatment for pediatric Acute myeloid leukemia.
- Baseline mannose binding lectin levels may not predict infection among children with Leukemia.
- Prognostic significance of myeloperoxidase expression in childhood Acute myeloid leukemia.
- Childhood Acute myeloid leukemia.
- Cumulative incidence of secondary neoplasms as a first event after childhood Acute lymphoblastic leukemia.
- Risk- and response-based classification of childhood B-precursor Acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Gr...
- Effect of race on outcome of white and black children with Acute myeloid leukemia: the St. Jude experience.
- Prognostic factors and outcome of recurrence in childhood Acute myeloid leukemia.
- Body mass index does not influence pharmacokinetics or outcome of treatment in children with Acute lymphoblastic leukemia.
- Prognostic significance of CD20 expression in childhood B-cell precursor Acute lymphoblastic leukemia.
- Near-triploidy and near-tetraploidy in childhood Acute lymphoblastic leukemia: association with B-lineage blast cells carrying the ETV6-RUNX1 fusion, T-lineage immunop...
- Impact of age on outcome of pediatric Acute myeloid leukemia: a report from 2 institutions.
- Risk of adverse events after completion of therapy for childhood Acute lymphoblastic leukemia.
- Lack of benefit of early detection of relapse after completion of therapy for Acute lymphoblastic leukemia.
- Severe cardiopulmonary complications consistent with systemic inflammatory response syndrome caused by leukemia cell lysis in childhood Acute myelomonocytic or monocyt...
- Gene expression profiling of pediatric Acute myelogenous leukemia.
- Death during induction therapy and first remission of Acute leukemia in childhood: the St. Jude experience.
- Results of therapy for Acute lymphoblastic leukemia in black and white children.
- Risk factors for traumatic and bloody lumbar puncture in children with Acute lymphoblastic leukemia.
- Interim comparison of a continuous infusion versus a short daily infusion of cytarabine given in combination with cladribine for pediatric Acute myeloid leukemia.
- Use of peripheral blood instead of bone marrow to monitor residual disease in children with Acute lymphoblastic leukemia.
- Skeletal manifestations of pediatric Acute megakaryoblastic leukemia.
- TEL/AML1-positive pediatric Leukemia: prognostic significance and therapeutic approaches.
- Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with Acute lymphoblastic ...
- Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood Acute lymphoblastic leukemia.
- Favorable impact of the t(9;11) in childhood Acute myeloid leukemia.
- Clinical significance of in vivo cytarabine-induced gene expression signature in AML.
Schools
University of California At San Diego
Stanford University
Chldns Hospital Stanford University
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
- Aetna
- Assurant Health
- Blue Card PPO
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- Emblem Health
- First Health (Coventry Health Care) PPO
- Golden Rule
- Group Health Cooperative
- HealthPartners
- Choice Care PPO
- Medicaid
- Medicare MCR
- Meritain Health
- MultiPlan PPO
- Qualchoice PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Stanford University -
University of California San Diego School of Medicine
Hospital
-
Le Bonheur Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Sneh A. Bhatnagar, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa M. Hudson, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Giles W. Robinson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Catherine G. Lam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Amar J. Gajjar, MB
This Doctor is OpenDoctor Recommended.
|
|
|
Hiroto Inaba, MB
This Doctor is OpenDoctor Recommended.
|